Original Article | Published:

Artificial Klebsiella pneumoniae biofilm model mimicking in vivo system: altered morphological characteristics and antibiotic resistance

The Journal of Antibiotics volume 67, pages 305309 (2014) | Download Citation


The purpose of this study was to develop a biofilm model of Klebsiella pneumoniae B5055, mimicking in vivo biofilm system so as to determine susceptibility of different phases of biofilm to antibiotics by three-dimensional analysis. Artificial mature biofilm of K. pneumoniae was made on black, polycarbonate membranes. Biofilm structure was visualized by scanning electron microscope (SEM) and confocal laser scanning microscopy (CLSM). Viable count method, CLSM and SEM analysis confirmed that mature, uniform and viable biofilms can be formed on the polycarbonate membranes by this method. The three-dimensional heterogeneity of biofilm was confirmed on the basis of results of CLSM, which is an important characteristics of in vivo biofilm system. Staining with the LIVE/DEAD BacLight viability kit and acridine orange suggested that the center of biofilm had more inactive cells compared with actively dividing cells on the periphery. Amikacin at a concentration of 40 μg ml−1 was effective against younger biofilm whereas ineffective against older biofilm that showed sparsely populated dead cells using the BacLight viability staining kit. Role of altered morphological characteristics toward increased antibiotic susceptibility was also studied for different phases of K. pneumoniae biofilm by CLSM and light microscopy. Thickness of biofilm increased from 0.093 to 0.231 mm with time. So, both heterogeneity and thickness of the biofilm are likely to influence the ineffectiveness of amikacin in older biofilm. The present model holds considerable clinical relevance and may be useful for evaluating the efficacy of antimicrobial agent on bacterial biofilms in vitro.

  • Subscribe to The Journal of Antibiotics for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    , & Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999).

  2. 2.

    , & Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95–108 (2004).

  3. 3.

    & Survival strategies of bacteria in the natural environment. Microbiol. Rev. 51, 365–379 (1987).

  4. 4.

    , & Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44, 1818–1824 (2000).

  5. 5.

    , & The estimation of the bactericidal power of the blood. J. Hyg. (Lond) 38, 732–749 (1938).

  6. 6.

    , , & Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 38, 138–141 (1994).

  7. 7.

    Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7, CLSI: Wayne, PA, USA, (2006).

  8. 8.

    & Biofilm thickness measurements by light microscopy. J. Microbiol. Methods 5, 93–98 (1986).

  9. 9.

    , , , & A modified CDC biofilm reactor to produce mature biofilms on the surface of PEEK membranes for an in vivo animal model application. Curr. Microbiol. 62, 1657–1663 (2011).

  10. 10.

    et al. Spatial patterns of DNA replication, protein synthesis and oxygen concentration within bacterial biofilms reveal diverse physiological states. J. Bacteriol 189, 4223–4233 (2007).

  11. 11.

    Diffusion in biofilms. J. Bacteriol. 185, 1485–1491 (2003).

  12. 12.

    , , , & Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl. Environ. Microbiol. 64, 4035–4039 (1998).

  13. 13.

    & Microbial biofilms: from ecology to molecular genetics. Microbiol. Mol. Biol. Rev. 64, 847–867 (2000).

  14. 14.

    & Spatial organization of microbial biofilm communities. Microb. Ecol. 40, 75–84 (2000).

  15. 15.

    , , & Spatial variations in growth rate within Klebsiella pneumoniae colonies and biofilm. Biotechnol. Prog. 12, 316–321 (1996).

  16. 16.

    & Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin. Chemotherapy 31, 204–210 (1985).

  17. 17.

    , & Analysis of biocide transport limitation in an artificial biofilm system. J. Appl. Microbiol. 85, 495–500 (1998).

Download references


This work was supported by funding from the Department of Science and Technology (DST), India, in the form of a research fellowship. We thank Mr Deepak Bhatt of the Institute of Microbial Technology (IMTECH), Chandigarh, India for assistance in the operation of confocal microscope.

Author information


  1. Department of Microbiology, Panjab University, Chandigarh, India

    • Saloni Singla
    • , Kusum Harjai
    •  & Sanjay Chhibber


  1. Search for Saloni Singla in:

  2. Search for Kusum Harjai in:

  3. Search for Sanjay Chhibber in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to Sanjay Chhibber.

About this article

Publication history







Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.